Trinucleotide repeat expansion and neuropsychiatric disease

Archives of General Psychiatry

Volumn 56, Issue 11, 1999, Pages 1019-1031

  Margolis, Russell L ^a,b   McInnis, Melvin G ^a   Rosenblatt, Adam ^a   Ross, Christopher A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Meyer 2 181 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEOTIDE;

ANTICIPATION; AUTISM; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MYOTONIC DYSTROPHY; NEUROLOGIC DISEASE; REVIEW; SCHIZOPHRENIA; TRINUCLEOTIDE REPEAT;

AUTISTIC DISORDER; BIPOLAR DISORDER; FRAGILE X SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; MENTAL DISORDERS; MUTATION; MYOTONIC DYSTROPHY; NEURODEGENERATIVE DISEASES; SCHIZOPHRENIA; TRINUCLEOTIDE REPEATS;

EID: 0032720224     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.11.1019     Document Type: Review

References (212)

1. McGuffin P, Murray RM. The New Genetics of Mental Illness. Oxford, England: Butterworth-Heinemann Ltd; 1991.
2. Gershon ES, Badner JA, Goldin LR, Sanders AR, Cravchik A, Detera-Wadleigh SD. Closing in on genes for manic-depressive illness and schizophrenia. Neuropsychopharmacology. 1998;18: 233-242.
3. Jamison KR, Mclnnis MG. Genetic studies of manic-depressive illness. Nat Med. 1996;2:521-522.
4. Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G, Ott J, Liang K-Y, Lamacz M, Thomas M, Childs B, Diehl SR, Wang S, Murphy B, Sun C, O'Neill A. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: part 2. Am J Med Genet. 1994;54:44-50.
5. McHugh PR, Slavney PR. The Perspectives of Psychiatry. Baltimore, Md: Johns Hopkins University Press; 1998.
6. MacKinnon DF, McMahon FJ, Simpson SG, McInnis MG, DePaulo JR. Panic disorder with familial bipolar disorder. Biol Psychiatry. 1997;42: 90-95.
7. McMahon FJ, Stine OC, Chase GA, Meyers DA, Simpson SG, DePaulo JR Jr. Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry. 1994;151:210-215.
8. Piven J, Palmer P, Landa R, Santangelo S, Jacobi D, Childress D. Personality and language characteristics in parents from multiple-incidence autism families. Am J Med Genet. 1997; 74:398-411.
9. Mclnnis MG, Margolis RL. Anticipation and psychiatric disease. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:401-411.
10. Levinson DF, Mowry BJ, Sharpe L, Endicott J. Penetrance of schizophrenia-related disorders in multiplex families after correction for ascertainment. Genet Epidemiol. 1996;13:11-21.
11. Turecki G, Rouleau G, Morgan K. Modeling the phenotype in parametric linkage analysis of bipolar disorder. Genet Epidemiol. 1997;14: 687-691.
12. Woolf CM. Does the genotype for schizophrenia often remain unexpressed because of canalization and stochastic events during development? Psychol Med. 1997;27:659-668.
13. Gottesman II, Bertelsen A. Confirming unexpressed genotypes for schizophrenia: risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry. 1989;46:867-872.
14. Kendler KS, Diehl SR. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull. 1993;19:261-285.
15. Nurnberger JI, DePaulo JR, Gershon ES, Recih T, Blehar MC, Edenberg HJ, Foroud T, Miller M, Bowman E, Mayeda A, Rau NL, Smiley R, Conneally PM, McManon F, Meyers D, Simpson S, McInnis M, Stine OC, Detera-Wadleigh S, Goldin L, Guroff J, Maxwell E, Kazuba D, Gejman PV. Genomic survey of bipolar illness in the NIMH Genetics Initiative pedigrees - a preliminary report. Am J Med Genet. 1997;74:227-237.
16. Berrettini WH, Ferraro TN, Goldin LR, Detera-Wadleigh SD, Choi H, Muniec D, Guroff JJ, Kazuba DM, Nurnberger JI, Hsieh WT, Hoehe MR, Gershon ES. A linkage study of bipolar illness. Arch Gen Psychiatry. 1997;54:27-35.
17. McMahon FJ, Hopkins PJ, Xu J, Mclnnis MG, Shaw S, Cardon L, Simpson SG, MacKinnon DF, Stine OC, Sherrington R, Meyers DA, DePaulo JR. Linkage of bipolar affective disorder to chromosome 18 markers in a new pedigree series. Am J Hum Genet. 1997;61:1397-1404.
18. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Pulver AE. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 1998;20:70-73.
19. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet. 1998;7:571-578.
20. Moises HW, Yang L, Kristbjarnaron H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B, Aschauer HN, Hwu H-G, Jang K, Livesley WJ, Kennedy JL, Zoega T, Ivarsson O, Bui M-T, Yu M-H, Havsteen B, Commenges D, Weissenbach J, Schwinger D, Gottesman II, Pakstis AJ, Wetterberg L, Kidd KK, Helgason T. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet. 1995;11:321-324.
21. Berrettini W. Progress and pitfalls: bipolar molecular linkage studies. J Affect Disord. 1998; 50:287-297.
22. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet. 1998;6:2233-2238.
23. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C, Mendlewicz J. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet. 1996;67:551-555.
24. Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS. Walsh D, Gill M. Examination of new and reported data of the DRD3/Mscl polymorphism: no support for the proposed association with schizophrenia. Mol Psychiatry. 1998; 3:150-155.
25. Berrettini W. On the interpretation of association studies in behavioral disorders. Mol Psychiatry. 1997;2:274-275.
26. Petronis A, Kennedy JL. Unstable genes - unstable mind? Am J Psychiatry. 1995;152:164-172.
27. Petronis A, Sherrington RP, Paterson AD, Kennedy JL. Genetic anticipation in schizophrenia: pro and con. Clin Neurosci. 1995;3:76-80.
28. Ross CA. Schizophrenia genetics: expansion of knowledge? Mol Psychiatry. 1999;4:4-5.
29. O'Donovan MC, Owen MJ. Dynamic mutations and psychiatric genetics. Psychol Med. 1996; 26:1-6.
30. Beckmann JS, Weber JL. Survey of human and rat microsatellites. Genome. 1992;12:627-631.
31. Stallings RL. Distribution of trinucleotide microsatellites in different categories of mammalian genomic sequence: implications for human genetic disease. Genome. 1994;21:116-121.
32. Kleiderlein JJ, Nisson PE, Jessee J, Li W-B, Becker KG, Derby ML, Ross CA, Margolis RL. CCG repeats in cDNA from human brain. Hum Genet. 1998;103:666-673.
33. Margolis RL, Abraham MA, Gatchell SB, Li S-H, Kidwai AS, Breschel TS, Stine OC, Callahan C, Mclnnis MG, Ross CA. cDNAs with long CAG trinucleotide repeats from human brain. Hum Genet. 1997;100:114-122.
34. Gerber H-P, Seipel K, Georgiev O, Hofferer M, Hug M, Rusconi S, Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 1994; 263:808-811.
35. Pearson CE, Sinden RR. Slipped strand DNA, dynamic mutations, and human disease. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:585-621.
36. Wells RD, Warren ST. Genetic Instabilities and Hereditary Neurological Diseases. San Diego: Academic Press Inc; 1998.
37. Rubinsztein DC, Hayden MR. Analysis of triplet repeat disorders. Oxford, England: Bios Scientific Publishers Ltd; 1998.
38. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72: 971-983.
39. Koide O, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6:9-13.
40. Nagafuchi S, Yanagisawa H, Soto K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furukawa T, Nihei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M. Dentatorubral and pallidoluysian atrophy is caused by an expansion of an unstable CAG trinucleotide repeat on chromosome 12p. Nat Genet. 1994;6:14-18.
41. Banfi S, Servadio A, Chung M-Y, Kwiatkowski TJ Jr, McCall AE, Duvick LA, Shen Y, Roth EJ, Orr HT, Zoghbi HY. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet. 1994;7:513-520.
42. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Gamier J-M, Weber C, Mandel J-L, Cancel G, Abbas N, Durr A, Didierjean O, Stevanin G, Agid Y, Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet. 1996;14:295-296.
43. Pulst S-M, Nechiporuk A, Nechiporuk T, Gispert S, Chen X-N, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S. Moderate expansion of a normal biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14:209-276.
44. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Saito A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nommura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsujl S. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet. 1996;14:227-284.
45. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease. Nat Genet. 1996; 13:196-202.
46. David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel J-L, Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997; 17:65-70.
47. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77-79.
48. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet. 1997; 15:62-69.
49. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D. Cole WG, Henn W, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997;89:773-779.
50. Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science. 1996;272:548-551.
51. Brais B, Bourchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, LaFreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korcyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998; 18:164-167.
52. Delot E, King LM, Briggs MO, Wilcox WR, Cohn DH. Trinucleotide expansion mutations in the cartilage oligomeric matrix protein (COMP) gene. Hum Mol Genet. 1999;8:123-128.
53. Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JJA, Fenmwick RG, Warren ST, Nelson DL, Caskey CT. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047-1058.
54. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905-914.
55. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richards RI. Fragile X genotype characterized by an unstable region of DNA. Science. 1992;252:1179-1981.
56. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, Pointon J, Middletonprice HR, Barnicoat A, Pembrey ME, Holland J, Oostra BA, Bobrow M, Davies KE. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993;74:127-134.
57. Jones C, Penny L, Mattina T, Yu S, Baker E, Voullaire L, Langdon WY, Sutherland GR, Richards RI, Tunnacliffe A. Association of a chromosome deletion syndrome with a fragile site with trie proto-oncogene CBL2. Nature. 1995;376: 145-149.
58. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;68:799-808.
59. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Nelville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-MacDonald J, DeJong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255:1253-1255.
60. Fu Y-H, Pizzuti A, Fenwick RG, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, De Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256-1258.
61. Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, Ranum LPW. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999;21: 379-384.
62. Holmes SE, O'Hearn E, Mclnnis MG, Gorelick-Feldman DA, Kleiderlein JK, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, Sharp AH, Ananth U, Seltze WK, Boss MA, Vieria-Saecker A-M, Epplen JT, Riess O, Ross CA, Margolis RL. Expansion of a CAG trinucleotide repeat in the 5′ region of the protein phosphatase 2A subunit gene PR55 is associated with a novel dominant ataxia (SCA12) in a single family. Nat Genet. In press.
63. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizares J, Koutnikova H, Bidichandani S, Gellera C, Brice A, Trouillas P, DeMichele G, Filla A, DeFrutos R, Palau F, Patel PI, Pragna I, DiDonato S, Mandel J-L, Cocozza S, Koenig M, Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423-1427.
64. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, Antonarakis SE. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature. 1997; 386:847-851.
65. LaFreniere RG, Rochefort DL, Chretien N, Rommens JM, Cochius JI, Kalviainen R, Nousiainen U, Patry G, Farrell K, Soderfeldt B, Federico A, Hale BR, Cossio OH, Sorensen T, Pouliot MA, Kmiec T, Uldall P, Janszky J, Pranzatelli MR, Andermann F, Andermann E, Rouleau GA. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet. 1997;15:298-302.
66. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet. 1997;6:2005-2010.
67. Ross CA, Margolis RL, Becher MW, Wood JD, Engelender S, Sharp AH. Pathogenesis of polyglutamine neurodegenerative diseases: towards a unifying mechanism. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:761-776.
68. Ross CA. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. 1995;15:493-496.
69. Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, Aylward E. Reviews in molecular medicine: Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltimore). 1997;76:305-338.
70. Rosenberg RN. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology. 1995;45:1-5.
71. Ross CA. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 1997;19:1147-1150.
72. Robitaille Y, Lopes-Cendes I, Becher M, Rouleau G, Clark AW. The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol. 1997;7:901-926.
73. Schilling G, Sharp AH, Loev SJ, Wagster MV, Li S-H, Stine OC, Ross CA. Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet. 1995;4:1365-1371.
74. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science. 1997;277: 1990-1993.
75. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions (NII) underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537-548.
76. Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis. 1998; 4:387-397.
77. Skinner PJ, Koshy B, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, Orr HT. SCA1 pathogenesis involves alterations in nuclear matrix associated structures. Nature. 1997;389: 971-974.
78. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel J-L, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19: 333-344.
79. Harper PS. Myotonic dystrophy as a trinucleotide repeat disorder - a clinical perspective. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Disorders. San Diego, Calif: Academic Press Inc; 1998;115-130.
80. Llinas R, Sugimori M, Hillman DE, Cherksey B. Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system. Trends Neurosci. 1992;15:351-355.
81. Sherman S. Epidemiology. In: Hagerman RJ, Cronister A, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. Baltimore, Md: Johns Hopkins University Press; 1996:165-192.
82. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:817-822.
83. Imbert G, Feng Y, Nelson DL, Warren ST, Mandel J-L. FMR1 and mutations in fragile X syndrome: molecular biology, biochemistry, and genetics. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:27-53.
84. Hagerman RJ. Physical and behavioral phenotype. In: Hagerman RJ, Cronister A, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. Baltimore, Md: Johns Hopkins University Press; 1996:3-87.
85. Knight SJ, Ritchie RJ, Chakrabarti L, Cross G, Taylor GR, Mueller RF, Hurst J, Paterson J, Yates JR, Dow DJ, Davies KE. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am J Hum Genet. 1996;58:906-913.
86. Chakrabarti L, Knight SJ, Flannery AV, Davies KE. A candidate gene for mild mental handicap at the FRAXE fragile site. Hum Mol Genet. 1996;5: 275-282.
87. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 1996;13: 105-108.
88. Nelson DL. FRAXE mental retardation and other folate-sensitive fragile sites. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:65-73.
89. Hirst MC, Barnicoat A, Flynn G, Wang Q, Daker M, Buckle VJ, Davies KE, Bobrow M. The identification of a third fragile site, FRAXF in Xq27.3 distal to both FRAXA and FRAXE. Hum Mol Genet. 1993;2:197-200.
90. Nancarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, Le Paslier D, Callen DF, Sutherland GR, Richards RI. Implications of FRA16A structure for the mechanisms of chromosomal fragile site genesis. Science. 1994;264:1938-1941.
91. Yu S, Mangelsdorf M, Hewett D, Hobsen L, Baker E, Eyre HJ, Lapsys N, Le Paslier D, Doggett NA, Sutherland GR, Richards RI. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell. 1997;88:367-374.
92. Strong PN, Brewster BS. Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive. J Inherit Metab Dis. 1997;20:159-170.
93. Waring JD, Korneluk RG. Genetic studies of the myotonic dystrophy CTG repeat. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:131-146.
94. Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B, Mercier J, Poirier J, Capozzoli F, Bouchard J-P, Lemieux B, Mathieu J, Vanasse M, Seni M-H, Graham G, Andermann F, Andermann E, Melacon SB, Keats BJB, Di Donato S, Pandolfo M. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol. 1997;41:675-682.
95. Pandolofo M, Koenig M. Friedreich's ataxia. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego. Calif: Academic Press Inc; 1998:373-400.
96. Monros E, Molto MD, Martinez F, Canizares J, Blanca J, Vilchez JJ, Prieto F, de Frutos R, Palau F. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet. 1997;61: 101-110.
97. Brandt J, Folstein SE, Folstein MF. Differential cognitive impairment in Alzheimer disease and Huntington's disease. Ann Neurol. 1988;23:555-561.
98. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci. 1986;9:118-120.
99. Harper PS. Huntington Disease. London, England: WB Saunders Co; 1996.
100. Peyser CE, Folstein SE. Depression in Huntington disease. In: Starkstein SE, Robinson RG, eds. Depression in Neurologic Disease. Baltimore, Md: Johns Hopkins University Press; 1993:117-138.
101. Ikeuchi T, Koide R, Tanaka H, Onodera O, Igarashi S, Takahashi H, Kondo R, Ishikawa A, Tomoda A, Miike T, Sato K, Ihara Y, Hayabara T, Isa F, Tanabe H, Tokguchi S, Hayashi M, Shimizu N, Ikuta F, Naito H, Tsuji S. Dentatorubralpallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol. 1995;37:769-775.
102. Skre H. A study of certain traits accompanying some inherited neurological disorders. Clin Genet. 1975;8:117-135.
103. Berent S, Siordani B, Gilman S, Junck L, Lehtinen S, Markel DS, Boivin M, Kluin KJ, Parks R, Koeppe RA. Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol. 1990; 47:997-1001.
104. Storey E, Forrest SM, Shaw JH, Mitchell P, Gardner RJ. Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol. 1999;56: 43-50.
105. Kish SJ, El-Awar M, Stuss D, Nobrega J, Currier R, Aita JF, Schut L, Zoghbi HY, Freedman M. Neuropsychological test performance in patients with dominantly inherited spinocere bellar ataxia: relationship to ataxia severity. Neurology. 1994;44:1738-1746.
106. Maruff P, Tyler P, Burt T, Currie B, Burns C, Currie J. Cognitive deficits in Machado-Joseph disease. Ann Neurol. 1996;40:421-427.
107. Freund LS, Reiss AL, Hagerman R, Vinogradov S. Chromosome fragility and psychopathology in obligate female carriers of the fragile X chromosome. Arch Gen Psychiatry. 1992;49:54-60.
108. Mazzocco MM, Pennington BF, Hagerman RJ. Social cognition skills among females with fragile X. J Autism Dev Disord. 1994;24:473-485.
109. Hagerman RJ, Jackson C, Amiri K, Silverman AC, O'Connor R, Sobesky W. Girls with fragile X syndrome: physical and neurocognitive status and outcome. Pediatrics. 1992;89:395-400.
110. Dorn M, Mazzocco M, Hagerman RJ. Behav4 ioral and psychiatric disorders in adult fragile X carrier males. J Am Acad Child Adolesc Psychiatry. 1994;33:256-264.
111. Abrams MT, Doheny KF, Mazzocco MM, Knight SJ, Baumgardner TL, Freund LS, Davies KE, Reiss AL. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am J Med Genet. 1997; 74:73-81.
112. Barnicoat AJ, Wang Q, Turk J, Green E, Mathew CG, Flynn G, Buckle V, Hirst M, Davies K, Bobrow M. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet. 1997;34:13-17.
113. Mulley JC, Yu S, Loesch DZ, Hay DA, Donnelly A, Gedeon AK, Carbonell P, Lopez I, Glover G, Gabarron I, Yu PWL, Baker E, Haan EA, Hockey A, Knight SJL, Davies DE, Richards RI, Sutherland GR. FRAXE and mental retardation. J Med Genet. 1995;32:162-169.
114. Mendelian Inheritance in Man, OMIM [database online]. Entry No. 254800. Baltimore, Md: Johns Hopkins University Press; 1999.
115. Davies DL. Psychiatric changes associated with Friedreich'sataxia. J Neurol Neurosurg Psychiatry. 1949;12:246-250.
116. McInnis MG. Anticipation: an old idea in new genes. Am J Hum Genet. 1996;59:973-979.
117. Asherson P, Walsh C, Williams J, Sargeant M, Taylor C, Clements A, Gill M, Owen M, McGuffin P. Imprinting and anticipation: are they relevant to genetic studies of schizophrenia? Br J Psychiatry. 1994;164:619-624.
118. Harper PS, Harley HG, Reardon W, Shaw DJ. Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet. 1992;51:10-16.
119. Mott FW. Hereditary aspect of nervous and mental diseases. BMJ. 1910;2:1013-1020.
120. Mott FW. A lecture on heredity and insanity. Lancet. 1911;1:1251-1259.
121. Penrose LS. The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugenics. 1948;14:125-132.
122. Howeler CJ, Busch HFM, Geraedts JPM, Niermeijer MF, Staal A. Anticipation in myotonic dystrophy: fact or fiction? Brain. 1989;112:779-797.
123. Ridley RM, Frith CD, Crow TJ, Conneally PM. Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet. 1988;25:589-595.
124. La Spada AR. Trinucleotide repeat instability: genetic features and molecular mechanisms. Brain Pathol. 1997;7:943-963.
125. Gusella JF, MacDonald ME. Trinucleotide instability: a repeating theme in human inherited disorders. Annu Rev Med. 1996;47:201-209.
126. Rubinsztein DC, Amos B. Trinucleotide repeat mutation processes. In: Rubinsztein DC, Hayden MR, eds. Analysis of Triplet Repeat Disorders. Oxford, England: Bios Scientific Publishers Ltd; 1998:257-268.
127. Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, Chase GA, Brandt J, Folstein SE, Ross CA. Anticipation and instability of (CAG)n repeats in IT-15 in parent-offspring pairs with Huntington's disease. Am J Hum Genet. 1995;57: 593-602.
128. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J. Hollingsworth Z, Shoulson I, Bonilla E, Alvir J, Bickham-Conde J, Cha J-H, Dure L, Gomez F, Amos M, Sanchez-Ramos J, Snodgrass S, deYoung M, Wexler N, Moscowitz C, Penschazadeh G, MacFarlane H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, MacDonald M. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet. 1993; 4:387-392.
129. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet. 1993;4:398-403.
130. Zhou YX, Takiyama Y, Igarashi S, Li YF, Zhou BY, Gui DC, Endo K, Tanaka H, Chen ZH, Zhou LS, Fan MZ, Yang BX, Weissenbach J, Wang GX, Tsuji S. Machado-Joseph disease in four Chinese pedigrees: molecular analysis of 15 patients including two juvenile cases and clinical correlations. Neurology. 1997;48:432-485.
131. Trottier Y, Biancalana V, Mandel JL. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet. 1994;31:377-382.
132. Komure O, Sano A, Nishino N, Yamaguchi N, Ueno S, Kondoh K, Sano N, Takahashi M, Murayama N, Kondo I, Nagafuchi S, Yamada M, Kanazawa I. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology. 1995;45:143-149.
133. Mclnnis MG, McMahon FJ, Chase G, Simpson SG, Ross CA, DePaulo JR Jr. Anticipation in bipolar affective disorder. Am J Hum Genet. 1993; 53:385-390.
134. Simpson SG, Folstein SE, Meyers DA, DePaulo JR. Assessment of lineality in bipolar I linkage studies. Am J Psychiatry. 1992;149:1660-1665.
135. Gershon ES, Hamovit JH, Guroff JJ, Nurnberger JI. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry. 1987;44:314-319.
136. Klerman GL, Lavori PW, Rice J, Reich T, Endicott J, Andreasen NC, Keller MB, Hirschfield RM. Birth-cohort trends in rates of major depressive disorder among relatives of patients with affective disorder. Arch Gen Psychiatry. 1985; 42:689-693.
137. Nylander PO, Engstrom C, Chotai J, Wahlstrom J, Adolfsson R. Anticipation in Swedish families with bipolar affective disorder. J Med Genet. 1994;31:686-689.
138. Engstrom C, Thomlund AS, Johansson EL, Langstrom M, Chotai J, Adolfsson R, Nylander PO. Anticipation in unipolar affective disorder. J Aftect Disord. 1995;35:31-40.
139. Grigoroiu-Serbanescu M, Wickramaratne PJ, Hodge SE, Milea S, Mihailescu R. Genetic anticipation and imprinting in bipolar I illness. Br J Psychiatry. 1997;170:162-166.
140. Macedo A, Azevedo H, Coelho I, Dourado A, Valente J, Pato MT, Soares MS, Kennedy JL, Macciardi F, Pato CN. Genetic anticipation in Portuguese families with bipolar mood disorder. CNS Spectrums. 1999;4:25-31.
141. Bassett AS, Husted J. Anticipation or ascertainment bias in schizophrenia - Penrose's familial mental illness sample. Am J Hum Genet. 1997; 60:630-637.
142. Bassett AS, Honer WG. Evidence for anticipation in schizophrenia. Am J Hum Genet. 1994; 54:864-870.
143. Thibaut F, Martinez M, Petit M, Jay M, Campion D. Further evidence for anticipation in schizophrenia. Psychiatry Res. 1995;59:25-33.
144. Ohara K, Xu HD, Mori N, Suzuki Y, Xu DS, Wang ZC. Anticipation and imprinting in schizophrenia. Biol Psychiatry. 1997;42:760-766.
145. Chotai J, Engstrom C, Ekholm B, son Berg M-LJ, Adotfson R, Nylander PO. Anticipation in Swedish families with schizophrenia. Psychiatr Genet. 1995;5:181-186.
146. Gorwood P, Leboyer M, Falissard B, Jay M, Rouillon F, Feingold J. Anticipation in schizophrenia: new light on a controversial problem [published erratum appears in Am J Psychiatry. 1997;154: 590]. Am J Psychiatry. 1996;153:1173-1177.
147. Gorwood P, Leboyer M, Falissard B, Jay M, Rouillon F, Feingold J. Anticipation in schizophrenia: new light on a controversial problem [published erratum appears in Am J Psychiatry. 1997;154: 590]. Am J Psychiatry. 1996;153:1173-1177.
148. Gonwood P, Leboyer M, Falissard B, Rouillon F, Joy M, Feingold J. Further epidemiological evidence for anticipation in schizophrenia. Biomed Pharmacother. 1997;51:376-380.
149. Johnson JE, Cleary J, Ahsan H, Harkavy Friedman J, Malaspina D, Cloninger CR, Faraone SV, Tsuang MT, Kaufmann CA. Anticipation in schizophrenia: biology or bias? Am J Med Genet. 1997; 74:275-280.
150. Battaglia M, Bertella S, Bajo S, Binaghi F, Bellodi L. Anticipation of age of onset in panic disorder. Am J Psychiatry. 1998;155:590-595.
151. DeLong GR, Dwyer JT. Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective diseases. J Autism Dev Disord. 1988;18:593-600.
152. Piven J, Chase G, Landa R, Wzorek J, Gayle J, Cloud D, Folstein S. Psychiatric disorders in the parents of autistic individuals. J Am Acad Child Psychiatry. 1991;30:471-478.
153. Piven J, Palmer P, Jacobi D, Childress D, Arndt S. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry. 1997;154:185-190.
154. Myles-Worsley M, Coon H, Tiobech J, Collier J, Dale P, Wender P, Reimherr F, Polloi A, Byerley W. Genetic epidemiological study of schizophrenia in Palau, Micronesia: prevalence and familiality. Am J Med Genet. 1999;88:4-10.
155. McInnis MG, McMahon FJ, Crow T, Ross CA, DeLisi LE. Anticipation in schizophrenia: a review and reconsideration. Am J Med Genet. In press.
156. Yaw J, Myles-Worsley M, Hoff M, Holik J, Freedman R, Byerley W, Coon H. Anticipation in multiplex schizophrenia pedigrees. Psychiatr Genet. 1996;6:7-11.
157. Vieland VJ, Huang J. Statistical evaluation of age-at-onset anticipation: a new test and evaluation of its behavior in realistic applications. Am J Hum Genet. 1998;62:1212-1227.
158. Huang J, Vieland V. A new statistical test for age-of-onset anticipation: application to bipolar disorder. Genet Epidemiol. 1997;14:1091-1096.
159. Ricci E, Galluzzi G, Deidda G, Cacurri G, Colantoni B, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L. Progress in the molecular diagnosis of facioscapulohemeral muscular dystrophy and correlation between the number of Kpnl repeats at the 4q35 locus and clinical phenotype. Ann Neurol. 1999;45:751-757.
160. van den Ouweland AM, de Vries BB, Bakker PL, Deelen WH, de Graaff E, van Hemel JO, Oostra BA, Niermeijer MF, Halley DJ. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene. Am J Med Genet. 1994;51:482-485.
161. Vits L, De Boulle K, Reyniers E, Handig I, Darby JK, Oostra B, Willems PJ. Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Hum Genet. 1994;94:523-526.
162. Vaisanen ML, Haataja R, Leisti J. Decrease in the CGGn trinucleotide repeat mutation of the fragile X syndrome to normal size range during paternal transmission. Am J Hum Genet. 1996;59: 540-546.
163. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med. 1995; 1:159-167.
164. Brunner HG, Jansen G, Nillesen W, Nelen MR, de Die CEM, Howeler CJ, van Oost BA, Wieringa B, Ropers H-H, Smeets HJM. Reverse mutation in myotonic dystrophy. N Engl J Med. 1993; 238:476-480.
165. Malzac P, Biancalana V, Voelckel MA, Moncla A, Pellissier MC, Boccaccio I, Mattei JF. Unexpected inheritance of the (CCG)n trinucleotide expansion in a fragile X syndrome family. Eur J Hum Genet. 1996;4:8-12.
166. Kruyer H, Mila M, Glover G, Carbonell P, Ballesta F, Estivill X. Fragile X syndrome and the (CCG)n mutation: two families with discordant MZ twins. Am J Hum Genet. 1994;54:437-442.
167. n repeat in sporadic Huntington disease. Nat Genet. 1993;5:169-273.
168. Goldberg YP, Andrew SE, Theilmann J, Kremer B, Squitieri F, Telenius H, Brown JD, Hayden MR. Familial predisposition to recurrent mutations causing Huntington s disease: genetic risk to sibs of sporadic cases. J Med Genet. 1993;30:987-990.
169. Schols L, Gispert S, Vorgerd M, Menezes Vieira-Saecker AM, Blanke P, Auburger G, Amoiridis G, Meves S, Epplen JT, Przuntek H, Pulst SM, Riess O. Spinocerebellar ataxia type 2: genotype and phenotype in German kindreds. Arch Neurol. 1997;54:1073-1080.
170. Tsuang MT, Gilbertson MW, Faraone SV. The genetics Df schizophrenia: current knowledge and future directions. Schizophr Res. 1991;4:157-171.
171. Gershon ES. Genetics. In: Goodwin FK, Jamison KR, eds. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990:373-401.
172. McMahon FJ, DePaulo JR. Affective disorders. In: Jameson JL, ed. Principles of Molecular Medicine. Totowa, NJ: Humana Press Inc; 1998:995-1003.
173. Brando LJ, Yolken R, Herman MM, Ross CA, Torrey EF. Analysis of the DRPLA triplet repeat in brain tissue and leukocytes and schizophrenia. Psychiatr Genet. 1996;6:1-5.
174. Morton NE, Macpherson JN. Population genetics of the fragile-X syndrome: multiallelic model tor the FMR1 locus. Proc Natl Acad Sci U S A. 1992;89:4215-4217.
175. Chandy KG, Fantino E, Wittekindt O, Kalman K, Tong LL, Ho TH, Gutman GA, Crocq MA, Ganguli R, Nimgaonkar V, Morris-Rosendahl DJ, Gargus JJ. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? Mol Psychiatry. 1998;3:32-37.
176. Bowenm T, Guy CA, Craddock N, Cardno AG, Williams NM, Spurlock G, Murphy KC, Jones LA, Gray M, Sanders RD, McCarthy G, Chandy KG, Fantino E, Kalman K, Gutman GA, Gargus JJ, Williams J, McGuffin P, Owen MJ, O'Donovan MC. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Mol Psychiatry. 1998; 3:266-269.
177. Stober G, Jatzke S, Meyer J, Okladnova O, Knapp M, Beckmann H, Lesch KP. Short CAG repeats within the hSKCa3 gene associated with schizo4 phrenia: results of a family-based study. Neuroreport. 1998;9:3595-3599.
178. Li T, Hu X, Chandy KG, Fantino E, Kalman K, Gutman G, Gargus JJ, Freeman B, Murray RM, Dawson E, Liu X, Bruinvels AT, Sham PC, Collier DA. Transmission disequilibrium analysis of a triplet repeat within the hKCA3 gene using family trios with schizophrenia. Biochem Biophys Res Commun. 1998;251:662-665.
179. McInnis MG, Breschel TS, Margolis RL, Chiles J, MacKinnon DF, McMahon FJ, Simpson SG, Ross CA, DePaulo JR. Family-based association analysis of the hSKCa3 potassium channel gene in bipolar disorder. Mol Psychiatry. 1999; 4:217-219.
180. Margolis RL, Stine OC, Mclnnis MG, Ranen NG, Rubinsztein DC, Leggo J, Jones Brando LV, Kidwai AS, Loev SJ, Breschel TS, Callahan C, Simpson SG, DePaulo JR, McMahon FJ, Jain S, Paykel ES, Walsh C, DeLisi LE, Crow TJ, Torrey EF, Ashworth RG, Macke JP, Nathans J, Ross CA. cDNA cloning of a human homologue of the C. elegans cell fate-determining gene mab-21: expression, chromosomal localization, and analysis of a highly polymorphic (CAG)n trinucleotide repeat. Hum Mol Genet. 1996;5:607-616.
181. Margolis RL, Ross CA. Detection of unstable trinucleotide repeat loci: genome and cDNA screening. In: Wells RD, Warren ST, eds. Genetic Instabilities and Hereditary Neurological Diseases. San Diego, Calif: Academic Press Inc; 1998:431-438.
182. Breschel T, McInnis MG, Margolis RL, Sirugo G, Corneliuseen B, Simpson SG, McMahon FJ, MacKinnon DF, Xu JF, Pleasant N, Huo Y, Ashworth RG, Grundstrom C, Grundstrom T, Kidd KK, DePaulo JR, Ross CA. A novel, heritable, expanding CTG repeat in an intron of SEF2-1 localizes to human chromosome 18q21.1. Hum Mol Genet. 1997;6:1855-1864.
183. Lesch KP, Stober G, Balling U, Franzek E, Li SH, Ross CA, Newman M, Beckmann H, Riederer P. Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia. J Neural Transm Sen Section. 1994;98: 153-157.
184. Jain S, Leggo J, Margolis RL, Li S-H, Crow TJ, DeLisi LE, Goodburn S, Walsh C, Paykel ES, Ferguson-Smith MA, Ross CA, Rubinsztein DC. Analysis of trinucleotide repeat loci as candidate genes for schizophrenia and bipolar affective disorder. Am J Med Genet. 1996;67:139-146.
185. Rubinsztein DC, Leggo J, Goodburn S, Barton DE, Ferguson-Smith MA, Ross CA, Lofthouse R, Crow TJ, DeLisi LE. B37 repeats are normal in most schizophrenic patients. Br J Psychiatry. 1994;164:851-852.
186. Rubinsztein DC, Leggo J, Crow TJ, DeLisi LE, Walsh C, Jain S, Paykel ES. Analysis of polyglutamine-coding repeats in the TATA-binding protein In different human populations and in patients with schizophrenia and bipolar affective disorder. Am J Med Genet. 1996;67:495-498.
187. Speight G, Guy C, Bowen T, Asherson P, McGuffin P, Craddock N, Owen MJ, 0'Donovan MC. Exclusion of CAG/CTG trinucleotide repeat loci which map to chromosome 4 in bipolar disorder and schizophrenia. Am J Med Genet. 1997; 74:204-206.
188. Gastier JM, Brody T, Pulido JC, Businga T, Sunden S, Hu X, Maitra S, Buetow KH, Murray JC, Sheffield VC, Boguski M, Duyk GM, Hudson TJ. Development of a screening set for new (CAG/ CTG)n dynamic mutations. Genome. 1996;32: 75-85.
189. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel J-L. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995;378:403-406.
190. Joober R, Benkelfat C, Jannatipour M, Turecki G, Lal S, Mandel J-L, Bloom D, Lalonde P, Lopes-Cendes I, Fortin D, Rouleau G. Polyglutamine-containing proteins in schizophrenia. Mol Psychiatry. 1999;4:53-57.
191. Moriniere S, Saada C, Holbert S, Sidransky E, Galat A, Ginns E, Rapoport JL, Neri C. Detection of polyglutamine expansion in a new acidic protein: a candidate for childhood onset schizophrenia? Mol Psychiatry. 1999;4:58-63.
192. Jones AL, Middle F, Guy C, Spurlock G, Cairns NJ, McGuffin P, Craddock N, Owen M, O'Donovan MC. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Mol Psychiatry. 1997;2:478-482.
193. Schalling M, Hudson TJ, Buetow KW, Housman DE. Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet. 1993;4:135-139.
194. Koob MD, Benzow KA, Bird TD, Day JW, Moseley ML, Ranum LPW. Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nat Genet. 1998;18:72-75.
195. O'Donovan MC, Guy C, Craddock N, Bowen T, McKeon P, Macedo A, Maier W, Wildenauer D, Aschauer HN, Sorbi S, Feldman E, Mynett-Johnson L, Claffey E, Nacmias B, Valente J, Dourado A, Grassi E, Lenzinger E, Heiden AM, Moorhead S, Harrison D, Williams J, McGuffin P, Owen MJ. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychol Med. 1996;26: 1145-1153.
196. Lindblad K, Nylander P-O, Zander C, Yuan Q-P, Stahle L, Engstrom C, Balciuniene J, Pettersson U, Breschel T, Mclnnis M, Ross CA, Adolfsson R, Schalling M. Two commonly expanded CAG/ CTG repeat loci: involvement in affective disorders? Mol Psychiatry. 1998;3:405-410.
197. Mendlewicz J, Lindbald K, Souery D, Manieu B, Nylander PO, De bruyn A, Zander C, Engstrom C, Adolfsson R, Van Broeckhoven C, Schalling M, Lipp O. Expanded trinucleotide CAG repeats in families with bipolar affective disorder. Biol Psychiatry. 1997;42:1115-1122.
198. Lindblad K, Nylander PO, De bruyn A, Sourey D, Zander C, Engstrom C, Holmgren G, Hudson T, Chotai J, Mendlewicz J, Van Broeckhoven C, Schalling M, Adolfsson R. Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol Dis. 1995;2:55-62.
199. Vincent JB, Klempan T, Parikh SS, Sasaki T, Meltzer HY, Sirugo G, Cola P, Petronis A, Kennedy JL. Frequency analysis of large CAG/CTG trinucleotide repeats in schizophrenia and bipolar affective disorder. Mol Psychiatry. 1996;1:141-148.
200. Vincent JB, Petronis A, Strong E, Parikh SV, Meltzer HY, Lieberman J, Kennedy JL. Analysis of genome-wide CAG/CTG repeats, and at SEF2-1B and ERDA1 in schizophrenia and bipolar affective disorder. Mol Psychiatry. 1999;4:229-234.
201. Li T, Vallada HP, Liu X, Xie T, Tang X, Zhao J, O'Donovan MC, Murrary RM, Sham PC, Collier DA. Analysis of CAG/CTG repeat size in Chinese subjects with schizophrenia and bipolar affective disorder using the repeat expansion detection method. Biol Psychiatry. 1998;44:1160-1165.
202. Zander C, Schurhoff F, Laurent C, Chavand O, Bellivier F, Samolyk D, Leboyer M, Allilaire JF, Cann H, Neri C, Mallet J. CAG repeat sequences in bipolar affective disorder: no evidence for association in a French population. Am J Med Genet. 1998;81:338-341.
203. Morris AG, Gaitonde E, McKenna PJ, Mollon JD, Hunt DM. CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset. Hum Mol Genet. 1995; 4:1957-1961.
204. Burgess CE, Lindblad K, Sidransky E, Yuan Q-P, Breschel T, Ross CA, McInnis MG, Lee P, Ginns E, Lenane M, Kumra S, Jacobsen L, Rapoport JL, Schalling M. Large CAG/CTG repeats are associated with childhood-onset schizophrenia. Mol Psychiatry. 1998;3:321-327.
205. Laurent C, Zander C, Thibaut F, Bonnet-Brilhault F, Chavand O, Jay M, Samolyk D, Petit M, Martinez M, Neri C, Campion D, Mallet J, Cann H. Anticipation in schizophrenia: no evidence of expanded CAG/CTG repeat sequences in French families and sporadic cases. Am J Med Genet. 1998;81:342-346.
206. Petronis A, Bassett AS, Honer WG, Vincent JB, Tatuch Y, Sasaki T, Ying DJ, Klempan TA, Kennedy JL. Search for unstable DNA in schizophrenia families with evidence for genetic anticipation. Am J Hum Genet. 1996;59:905-911.
207. Vincent JB, Kalsi G, Klempan T, Tatuch Y, Sherrington RP, Breshcel T, Mclnnis MG, Brynjolfsson J, Petursson H, Gurling HM, Gottesman II, Torrey EF, Petronis A, Kennedy JL. No evidence of expansion of CAG or GAA repeats in schizophrenia families and monozygotic twins. Hum Genet. 1998;103:41-47.
208. Martorell L, Pujana MA, Valero J, Joven J, Volpini V, Labad A, Estivill X, Vilella E. Anticipation is not associated with CAG repeat expansion in parent-offspring pairs of patients affected with schizophrenia. Am J Med Genet. 1999;88:50-56.
209. Ikeuchi T, Sanpei K, Takano H, Sasaki H, Tashiro K, Cancel G, Brice A, Bird TD, Schellenberg GD, Pericak-Vance MA, Welsh-Bohmer KA, Clark LN, Wilhelmsen K, Tsuji S. A novel long and unstable CAG/CTG trinucleotide repeat on chromosome 17. Genome. 1998;49:321-326.
210. Nakamoto M, Takebayashi H, Kawaguchi Y, Narumiya S, Taniwaki M, Nakamura Y, Ishikawa Y, Akiguchi I, Kimura J, Kakizuka A. A CAG/CTG expansion in the normal population. Nat Genet. 1997;17:385-386.
211. Sidransky E, Burgess C, Ikeuchi T, Lindblad K, Long RT, Philibert RA, Rapoport J, Schalling M, Tsuji S, Ginns El. A triplet repeat on 17q accounts for most expansions detected by the repeat-expansion-detection technique. Am J Hum Genet. 1998;62:1548-1551.
212. Haaf T, Sirugo G, Kidd KK, Ward DC. Chromosomal localization of long trinucleotide repeats in the human genome by fluorescence in situ hybridization. Nat Genet. 1996;12:183-185.